On October 30–31, the NIH, with support from the Alliance for Aging Research and the Gerontological Society of America, will host “Advances in Geroscience: Impacts on Healthspan and Chronic Disease.” The scientific conference, which will take place on the NIH campus in Bethesda, MD, will examine the extent to which the physiological effects of aging represent a common major risk factor for chronic diseases.
The objectives of the summit are:
The meeting will begin with a plenary session featuring a lecture by NIH Director Dr. Francis S. Collins. Other speakers in the session will be Drs. Brian Kennedy of the Buck Institute, Linda Fried of Columbia University, and Chris Murray of the University of Washington. This will be followed by seven scientific sessions looking at major intersections of aging and disease. Using a panel discussion format led by renowned scientists in the field, the sessions will focus on inflammation, adaptation to stress, epigenetics and regulatory RNA, metabolism, macromolecular damage, proteostasis, and stem cells and regeneration.
The summit program is the brainchild of the Trans-NIH GeroScience Interest Group (GSIG). Established in October 2011, the GSIG focuses on many of the same relationships between aging and age-related disease and disability that will be discussed at the Geroscience Summit. Dr. Felipe Sierra, director of the NIA Division of Aging Biology (DAB), Dr. Ronald Kohanski, DAB deputy director, and Dr. Kevin Howcroft, program director in the Cancer Immunology and Hematology Branch of the National Cancer Institute, led development of the summit program.
The overall goals of GSIG are:
Participation in the GSIG summit is free, but pre-registration is required.